Viral Hemorrhagic Fever
Symptoms, Doctors, Treatments, Advances & More

Viral Hemorrhagic Fever Overview

Save information for later
Sign Up

Learn About Viral Hemorrhagic Fever

What is the definition of Viral Hemorrhagic Fever?
Viral hemorrhagic fevers is a term used to describe a group of illnesses caused by four different families of viruses that severely affect multiple body systems. Some of the more commonly known types of viral hemorrhagic fevers include Ebola virus, Lassa fever, Hantavirus, Tick-borne encephalitis, and Rift Valley fever. Viral hemorrhagic fevers are carried by insects, rats, and mice and are limited to specific geographical areas in which the insects and animals live, such as West Africa (Lassa fever). While humans can be infected by contact with an infected insect or animal, these viruses can also be transmitted from one human to another and are highly contagious.
What are the symptoms of Viral Hemorrhagic Fever?
While certain types of viral hemorrhagic fevers may cause only mild illness, many of these can cause severe, life-threatening symptoms, and even death. Symptoms may also include muscle aches, extreme fatigue, and high fever. An infected person’s vascular system is often damaged, while the body loses ability to regulate. Vascular damage causes hemorrhage (bleeding).
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Viral Hemorrhagic Fever?
Most viral hemorrhagic diseases have no treatment. However, the antiviral drug, ribavirin, may help to shorten the course of illness, and, in some cases, may even prevent infection. Patients are mainly treated with supportive care, which includes prevention of dehydration. Some patients may need kidney dialysis in the event of kidney failure.
Who are the top Viral Hemorrhagic Fever Local Doctors?
Jesse Waggoner
Elite in Viral Hemorrhagic Fever
Dr. Jesse Waggoner
Infectious Disease
Elite in Viral Hemorrhagic Fever
Dr. Jesse Waggoner
Infectious Disease

Emory University Hospital Midtown Campus

550 Peachtree Street Northeast, MedicalOfficeTower, 
Atlanta, GA 
404-686-8114
Experience:
20+ years
Languages Spoken:
English
See accepted insurances

Jesse Waggoner is an Infectious Disease provider in Atlanta, Georgia. Dr. Waggoner has been practicing medicine for over 20 years and is rated as an Elite provider by MediFind in the treatment of Viral Hemorrhagic Fever. His top areas of expertise are Dengue Fever, Viral Hemorrhagic Fever, Zika Virus Disease, and Togaviridae Disease.

Elite in Viral Hemorrhagic Fever
Dr. Anna P. Durbin
Infectious Disease
Elite in Viral Hemorrhagic Fever
Dr. Anna P. Durbin
Infectious Disease

The Johns Hopkins Hospital

1800 Orleans Street, 
Baltimore, MD 
410-955-5000
Languages Spoken:
English
See accepted insurances

Dr. Anna Durbin is an associate professor at the Johns Hopkins University School of Medicine. Her area of clinical expertise is infectious disease. Dr. Durbin earned her M.D. from Wayne State University School of Medicine. She completed her residency and performed a fellowship in infectious diseases at Detroit Medical Center. She has expertise in the evaluation of live attenuated flavivirus vaccines, primary dengue and West Nile virus vaccines, and the early evaluation of malaria vaccines. She has served on national and international advisory boards and committees related to dengue and malaria vaccine safety. An important research interest of hers is studying the immunopathogenesis of dengue infection and disease. In addition to her clinical studies, her laboratory is also developing an animal model of dengue using rhesus macaques. Dr. Durbin is rated as an Elite provider by MediFind in the treatment of Viral Hemorrhagic Fever. Her top areas of expertise are Dengue Fever, Viral Hemorrhagic Fever, Arbovirosis, and Yellow Fever.

 
 
 
 
Learn about our expert tiers
Learn More
Stephen J. Thomas
Elite in Viral Hemorrhagic Fever
Dr. Stephen J. Thomas
Family Medicine
Elite in Viral Hemorrhagic Fever
Dr. Stephen J. Thomas
Family Medicine

Mdvip

575 Professional Drive, Suite 310, 
Lawrenceville, GA 
678-376-5858
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Stephen Thomas is a primary care provider, practicing in Family Medicine in Lawrenceville, Georgia. Dr. Thomas is rated as an Elite provider by MediFind in the treatment of Viral Hemorrhagic Fever. His top areas of expertise are Dengue Fever, Viral Hemorrhagic Fever, Japanese Encephalitis, Zika Virus Disease, and Tenotomy. Dr. Thomas is currently accepting new patients.

View All Doctors
What are the latest Viral Hemorrhagic Fever Clinical Trials?
The Association Between Prior Exposure to Dengue Tetravalent Vaccine (Live, Attenuated) (TDV) and Dengue Hospitalization in a Pediatric and Adolescent Population: A Nested Case-Control Post-Authorization Effectiveness Study
The Association Between Prior Exposure to Dengue Tetravalent Vaccine (Live, Attenuated) (TDV) and Dengue Hospitalization in a Pediatric and Adolescent Population: A Nested Case-Control Post-Authorization Effectiveness Study
Enrollment Status: Recruiting
Publish Date: April 16, 2026
Intervention Type: Other

Summary: The main aim of this study is to collect more information on the effectiveness of TDV when used in a pilot public vaccination program for children and adolescents participating in a community-based cohort in Southeast Asian countries with high dengue transmission, specifically Thailand, Indonesia, and Malaysia where TDV is already approved for use. The study will include cohort participants (indiv...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine (Butantan-DV) in Patients With Autoimmune Rheumatic Diseases Living in Dengue-Endemic Areas
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine (Butantan-DV) in Patients With Autoimmune Rheumatic Diseases Living in Dengue-Endemic Areas
Enrollment Status: Recruiting
Publish Date: April 15, 2026
Intervention Type: Biological
Study Phase: Phase 4

Summary: The goal of this clinical trial is to evaluate whether the live attenuated tetravalent Butantan-Dengue vaccine (Butantan-DV) is safe and capable of inducing an immune response in patients aged 12 to 59 years with autoimmune rheumatic diseases (ARDs) who are clinically stable and under low-grade or no immunosuppression, as well as in healthy volunteers matched by sex and age. The main questions it ...

View All Clinical Trials